UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
South Plains Financial
SPFI
$841M
| $231K | ﹤0.01% |
+8,400
| New | +$250K |
|
2352
Smith & Wesson
SWBI
$637M
| $230K | ﹤0.01% |
26,477
| – | – |
|
|
AEVA
2353
Aeva Technologies
AEVA
$1.86B
| $230K | ﹤0.01% |
33,775
-8,708
| -20% | -$76.3K |
|
2354
Aehr Test Systems
AEHR
$3.36B
| $229K | ﹤0.01% |
+11,400
| New | +$244K |
|
|
EGRX
2355
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $228K | ﹤0.01% |
7,799
| – | – |
|
2356
Lexicon Pharmaceuticals
LXRX
$1.1B
| $227K | ﹤0.01% |
119,046
| – | – |
|
|
LX
2357
LexinFintech Holdings
LX
$241M
| $227K | ﹤0.01% |
119,295
+90,400
| +313% | +$151K |
|
2358
Universal Logistics Holdings
ULH
$529M
| $226K | ﹤0.01% |
+6,769
| New | +$237K |
|
2359
Ducommun
DCO
$2.98B
| $225K | ﹤0.01% |
+4,503
| New | +$214K |
|
2360
Telos
TLS
$358M
| $224K | ﹤0.01% |
44,084
| – | – |
|
2361
Thryv Holdings
THRY
$108M
| $222K | ﹤0.01% |
11,700
| – | – |
|
2362
Traeger
COOK
$172M
| $222K | ﹤0.01% |
1,576
+1,026
| +187% | +$172K |
|
2363
EVgo
EVGO
$229M
| $222K | ﹤0.01% |
49,558
+26,700
| +117% | +$173K |
|
|
VLD
2364
DELISTED
Velo3D, Inc.
VLD
| $220K | ﹤0.01% |
3,509
+541
| +18% | +$52.6K |
|
2365
PLAYSTUDIOS Inc
MYPS
$90.1M
| $219K | ﹤0.01% |
56,419
| – | – |
|
2366
Rimini Street
RMNI
$471M
| $218K | ﹤0.01% |
57,096
| – | – |
|
2367
Nomad Foods
NOMD
$1.68B
| $217K | ﹤0.01% |
12,584
-2,176
| -15% | -$34.5K |
|
2368
Organogenesis Holdings
ORGO
$239M
| $217K | ﹤0.01% |
80,615
| – | – |
|
|
RDFN
2369
DELISTED
Redfin
RDFN
| $216K | ﹤0.01% |
51,007
-62,908
| -55% | -$296K |
|
2370
Smartbird Inc
BIRD
$22.3M
| $216K | ﹤0.01% |
4,462
| – | – |
|
2371
Similarweb
SMWB
$658M
| $213K | ﹤0.01% |
33,200
| – | – |
|
2372
Axogen
AXGN
$2.5B
| $213K | ﹤0.01% |
+21,390
| New | +$238K |
|
2373
Rush Enterprises Class B
RUSHB
$6.14B
| $212K | ﹤0.01% |
+5,651
| New | +$200K |
|
|
POSH
2374
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $212K | ﹤0.01% |
+11,855
| New | +$210K |
|
2375
Arlo Technologies
ARLO
$1.65B
| $211K | ﹤0.01% |
60,108
| – | – |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.